glp-1 employer coverage news october 2025 Massachusetts cuts for 460K public workers and retirees, jeopardizing obesity care and risking higher long-term health costs. Learn more Most insurance plans don’t cover

GLP-1 receptor agonists are no longer niche therapies

Your provider can review your BMI, health history, medications, weight loss goals, prior treatment experience, side effects, and budget to help determine which GLP-1 or GLP-1/GIP option may be appropriate

If an insurance plan doesnt cover Wegovy or Zepbound, these out-of-pocket programs with Novo Nordisk and Eli Lilly can be a way for patients to still access these drugs. In the last few years, both drugs had been in short supply due to manufacturing issues and high demand

Always consult your prescriber before restarting after extended breaks

Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study

lalarn ithalat iin her zaman gmrk ilemlerinin yaplmas ve ithalat tarafn aktif ibirlii gerektii unutulmamaldr